Cholecystectomy Prognosis
Cholecystectomy Prognosis - Related Videos
03:27
The Role of Indocyanine Green Fluorescence in Complex Laparoscopic Cholecystectomy Navigation
0 Views •
Cited by 3 •
2025
This protocol outlines the steps for fluorescence-guided laparoscopic cholecystectomy and elucidates the role of fluorescence navigation in diverse surgical scenarios.
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
0 Views •
Cited by 2 •
2020
Development of major adverse cardiovascular events, which impact cardiovascular prognosis after coronary angioplasty, are influenced by the extent of coronary damage and vascular repair. The use of novel coronary cellular and soluble biomarkers, reactive to vascular damage and repair, are useful to predict the development of MACEs and prognosis.
04:02
Laparoscopic Cholecystectomy with Indocyanine Green Fluorescence: Choledochoscopic Stone Extraction and Primary Duct Suture
0 Views •
2025
The integrated technique described in this protocol achieves real-time biliary mapping via indocyanine green (ICG) fluorescence, minimally invasive stone clearance under direct visualization, and secure primary duct repair (6-0 PDS), eliminating T-tube drainage.
08:25
A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
0 Views •
2025
This protocol describes a rat-based intestinal transplantation model with ileostomy for time-course assessment of drug intervention on graft rejection.
07:32
Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
0 Views •
Cited by 5 •
2024
The presence of mast cells in the inner margin and peritumor areas of hepatocellular carcinoma after resection confers a favorable prognosis. This study endorses QuPath image analysis software as a promising platform that could meet the need for reproducibility, consistency, and accuracy in digital pathology.
FAQs
A patient’s expected course depends on the surgical approach, overall health, and severity of the disease being treated. These factors help explain why recovery time and complication risk differ between individuals. Prognostic discussions therefore need to consider the person’s clinical context rather than relying on a single expected recovery pattern.
Removal does not stop bile production or its passage to the intestine. Bile continues to flow from the liver through the bile ducts, so the digestive process can continue without the gallbladder. This mechanism helps clinicians explain why gallbladder removal can be compatible with ongoing digestion while assessing whether symptoms improve after surgery.
Prognosis includes more than symptom improvement: clinicians also consider possible infection, bile leakage, bleeding, and persistent digestive symptoms. These outcomes can change the anticipated recovery and require postoperative monitoring. Reviewing them during prognostic assessment supports informed consent and helps the care team plan appropriate follow-up if recovery does not proceed as expected.
The surgical approach is a central prognostic variable because laparoscopic and open cholecystectomy can be associated with different recovery times. The overview does not assign one universal timeline to either approach; instead, recovery expectations must be interpreted alongside overall health and disease severity. This comparison helps clinicians provide individualized information before and after surgery.
Prognostic assessment is used before surgery to support informed consent and treatment planning, then after surgery to guide monitoring and follow-up care. It connects the expected recovery with the possibility of complications or continuing digestive symptoms. In this way, prognosis functions as an ongoing clinical framework rather than a one-time prediction made at the operation.
Monitoring focuses on whether recovery is progressing as expected and whether complications such as infection, bile leakage, or bleeding emerge. Clinicians also consider persistent digestive symptoms when reviewing the outcome. The findings can inform follow-up care and treatment planning, particularly when the patient’s recovery differs from the anticipated course based on the operation and disease severity.